Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Strata Critical Medical's Depreciation & Amortization (CF) rose 3322.91% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 751.84%. This contributed to the annual value of $6.0 million for FY2024, which is 1615.81% down from last year.
  • Latest data reveals that Strata Critical Medical reported Depreciation & Amortization (CF) of $1.7 million as of Q3 2025, which was up 3322.91% from $1.8 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Depreciation & Amortization (CF) high stood at $2.3 million for Q2 2022, and its period low was $126000.0 during Q1 2021.
  • Over the past 5 years, Strata Critical Medical's median Depreciation & Amortization (CF) value was $1.6 million (recorded in 2023), while the average stood at $1.4 million.
  • As far as peak fluctuations go, Strata Critical Medical's Depreciation & Amortization (CF) soared by 80873.02% in 2022, and later crashed by 3060.23% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Depreciation & Amortization (CF) stood at $717000.0 in 2021, then skyrocketed by 176.71% to $2.0 million in 2022, then fell by 8.97% to $1.8 million in 2023, then fell by 15.28% to $1.5 million in 2024, then increased by 11.37% to $1.7 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.7 million in Q1 2025.